François Aldrich

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Lydia D. Foster, Claudia S. Moy et al. · The Lancet Neurology · 2019 · 239 citations · Full text

Thrombosis, Reperfusion Injury, Deferoxamine Mesylate +11

Posterolateral microdiscectomy for cervical monoradiculopathy caused by posterolateral soft cervical disc sequestration

François Aldrich · Journal of neurosurgery · 1990 · 137 citations

Lumbosacral Radiculopathy, Spinal Cord Injury, Cervical Cancer +14

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Christine G. Lee, Brandy M. Heckman‐Stoddard, Dana Dabelea et al. · Diabetes Care · 2021 · 91 citations · Full text

Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])

Daniel Hänggi, Nima Etminan, François Aldrich et al. · Stroke · 2016 · 74 citations · Full text

Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage

Andrew P. Carlson, Daniel Hänggi, George K. C. Wong et al. · Stroke · 2020 · 69 citations